Aysun Komurcu

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld et al. · The Lancet Oncology · 2023 · 168 citations · Full text

Medicine, Oncology, Gastrointestinal Oncology +16

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases

Karen Bolhuis, Iris van ’t Erve, Clinton Mijnals et al. · EBioMedicine · 2021 · 41 citations · Full text

Medicine, Oncology, Pathology +17

Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Babette I Kuiper, Karen Bolhuis et al. · Annals of Surgical Oncology · 2023 · 17 citations · Full text

Medicine, Oncology, Surgery +14

FOLFOXIRI + bevacizumab versus FOLFOX/FOLFIRI + bevacizumab in patients with initially unresectable colorectal liver metastases (CRLM) and right-sided and/or <i>RAS</i>/<i>BRAFV600E-</i>mutated primary tumor: Phase III CAIRO5 study of the Dutch Colorectal Cancer Group.

Cornelis J.A. Punt, Marinde J. G. Bond, Karen Bolhuis et al. · Journal of Clinical Oncology · 2022 · 14 citations

Medicine, Oncology, Pharmacotherapy +17

The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial

Karen Bolhuis, Marinde J. G. Bond, Martin J. van Amerongen et al. · European Journal of Cancer · 2023 · 14 citations · Full text

Medicine, Oncology, Surgery +17